White House budget officials are reviewing a proposed rule to let states import drugs. The Trump administration this summer unveiled a two-track plan for allowing drug imports. The Office of Management and Budget on Oct. 4 began reviewing one of those tracks , which is a draft guidance for drug makers that want to avoid rebates by importing drugs they sell abroad that are identical to drugs sold in the United States. The track that OMB began reviewing on Friday...